Neuroblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed or Refractory Neuroblastoma
Conditions:   Neuroblastoma;   Refractory Neuroblastoma;   Relapsed Neuroblastoma Intervention:   Combination Product: Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate Sponsor:   Emory University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 1, 2022 Category: Research Source Type: clinical trials

Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta as Maintenance Therapy in Chinese Patients With High-risk Neuroblastoma
Condition:   High-risk Neuroblastoma Interventions:   Drug: Dinutuximab Beta;   Drug: 13 cis retinoic acid Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2022 Category: Research Source Type: clinical trials